Extended-Spectrum β-Lactamase and carbapenemase-producing Escherichia coli O157:H7 among diarrheic patients in Shashemene, Ethiopia
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306691 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Shimelis Teshome Ayalneh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, College of Health Sciences, Arsi University, Asela, Ethiopia. Hauptthemen laut MEDLINE: beta-Lactamases, Diarrhea, Escherichia coli O157, Escherichia coli Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The worldwide increase in multidrug resistance is a major threat to public health. One particular concern is the presence of Escherichia coli strains that carry Extended-Spectrum β-Lactamase (ESBL) and Carbapenemase enzymes, which can make multiple antibiotics ineffective. This complicates treatment strategies and raises the risk of illness and death. The aim of this study was to isolate E . coli O157:H7, assess its susceptibility against antimicrobial agents, and determine the presence of ESBL and Carbapenemase production in stool samples collected from diarrheic patients in Shashemene, west Arsi, Ethiopia from July to November 2022.
Methods
The samples were cultured McConkey Agar and E . coli were isolated and identified by standard biochemical tests using API 20E. E . coli O157:H7 was further identified using sorbitol McConkey Agar and antisera for O157 antigen test. The antimicrobial susceptibility test was performed using the Kirby–Bauer disc diffusion method using different antibiotics. Each identified isolate was screened and tested for phenotypical ESBL and Carbapenemase production using combined disc method and modified carbapenem inactivation method, respectively. Bivariant and multivariant analyses were employed using a logistic regression model for further analysis and were interpreted based on the odds ratio and level of statistical significance at a p-value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Sciences, College of Health Sciences, Arsi University, Asela, Ethiopia.
- Department of Microbiology, Immunology and Parasitology, School of Medicine, Collage of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
- Bacterial and Viral Disease Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
- Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.
- Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
- Yonsei University Graduate School of Public Health, Seoul, Republic of Korea.
ORCID-Profile: Shimelis Teshome Ayalneh, Tomas Getahun
Zitieren
APA
Ayalneh, S. T., Beshah, B. Y., Jeon, Y., Teshome, S., Getahun, T., Gebreselassie, S., Park, S. E., Teferi, M., & Abegaz, W. E. (2024). Extended-Spectrum β-Lactamase and carbapenemase-producing Escherichia coli O157:H7 among diarrheic patients in Shashemene, Ethiopia. PLOS ONE. https://doi.org/10.1371/journal.pone.0306691
Vancouver
Ayalneh ST, Beshah BY, Jeon Y, Teshome S, Getahun T, Gebreselassie S, et al. Extended-Spectrum β-Lactamase and carbapenemase-producing Escherichia coli O157:H7 among diarrheic patients in Shashemene, Ethiopia. PLOS ONE. 2024. doi:10.1371/journal.pone.0306691
BibTeX
@article{Ayalneh2024,
author = {Ayalneh, Shimelis Teshome and Beshah, Biruk Yeshitela and Jeon, Yeonji and Teshome, Seifegebriel and Getahun, Tomas and Gebreselassie, Solomon and Park, Se Eun and Teferi, Mekonnen and Abegaz, Woldaregay Erku},
title = {Extended-Spectrum β-Lactamase and carbapenemase-producing Escherichia coli O157:H7 among diarrheic patients in Shashemene, Ethiopia},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306691}
}
EUVIMED